Overview
Regulation / Supervision: CISA / FINMA (funds for qualified investors)
Authorised investors: pension funds, insurance companies, family offices and institutional investors under CISA
Investment: Equity securities issued by major Swiss companies listed in the SMI
Currently there are no investments in securities that are on the exclusion list of SVVK-ASIR (www.svvk-asir.ch)
Convertible and warrant bonds: none
Portfolio is passively managed and aims to replicate the gross performance of the benchmark (before fees)
Securities lending: not permitted
Use of derivatives: permitted under BVV2
Features
| Product category |
Equity Switzerland |
| Product domicile |
Switzerland
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Fund Management (Switzerland) AG
|
| Custodian bank |
麻豆社 Switzerland AG, Zurich
|
| Day of inception |
January 8, 2026
|
| Currency of account |
CHF
|
| Close of financial year |
October 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Maturity |
Open end
|
| Flat fee |
0.00% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SMI® (TR)
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
150625063
|
| ISIN |
CH1506250633
|
| Bloomberg Ticker |
UBCEIIX SW
|
Performance and Prices
Percentage growth
as of May 29, 2026
Cumulative
| CHF(%) | EUR(%) | USD(%) | |
| YTD | - | - | - |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | - | - | - |
| 3Y | |||
| 5Y | |||
| ø p.a.5Y |
Current data
| Net asset value | 29.05.2026 | CHF 1,017.85 |
| High - last 12 months | 27.05.2026 | CHF 1,024.22 |
| Low - last 12 months | 20.03.2026 | CHF 909.39 |
| Last distribution | 19.02.2026 | CHF 25.82 |
| Assets of the unit class in mn | 29.05.2026 | CHF 39.41 |
| Total product assets in mn | 29.05.2026 | CHF 147.62 |
Statistical data
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 30.04.2026 | 12.64% | 12.69% |
| Risk Free Rate | 30.04.2026 | 0.40% | 0.41% |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| Novartis AG | 16.77 |
| Roche Holding AG | 16.49 |
| Nestle SA | 15.01 |
| ABB Ltd | 9.13 |
| 麻豆社 Group AG | 7.80 |
| Zurich Insurance Group AG | 6.15 |
| Cie Financiere Richemont SA | 5.88 |
| Holcim AG | 2.85 |
| Swiss Re AG | 2.77 |
| Lonza Group AG | 2.48 |
Fees
Distributions
From
01-Nov-2020
To
01-Nov-2021
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Tax domicile CH gross amount
|
Tax domicile CH net amount
|
Tax domicile not CH gross amount
|
Tax domicile not CH net amount
|
|
| 17.02.2026 | 19.02.2026 | 1 | CHF | 25.82 | 16.78 | 25.82 | 16.78 |
Sales Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|
| Prospectus |
|
|
Annual and semi-annual report (accounting on October 31)
|
Document type
|
Document Language
|
|
| Annual report |
|
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.